A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Cited by (999)

Items 901–999 of 999

1. Cardiovascular Disease Assessment Prior to Kidney Transplantation
   Elise C. Ewing, Angelina R. Edwards · 2022 · Methodist DeBakey Cardiovascular Journal
2. Diabetes and cardiovascular disease
   Oliver Schnell, Eberhard Standl · 2010 · Clinical Research in Cardiology Supplements
3. Strategies in Stable Ischemic Heart Disease: Lessons from the COURAGE and BARI-2D Trials
   Stanley F. Fernandez, William E. Boden · 2010 · Current Atherosclerosis Reports
4. Screening of Silent Myocardial Ischemia in Type 2 Diabetic Patients
   Sophie Jacqueminet, Olivier Barthélémy, Claude Le Feuvre · 2010 · Diabetes Care
5. Doença arterial coronária e diabetes: do tratamento farmacológico aos procedimentos de revascularização
   Marinella Patrizia Centemero, Juliano Caetano Cherobin, Karina Vasconcelos Ferreira De Conti, Louis Nakayama Ohe, Nicki Mallmann, Alexandre Abizaid, Michael E. Farkouh, Valentı́n Fuster · 2009 · Revista Brasileira de Cardiologia Invasiva
6. The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines
   Mehul A. Pragani, Karan P. Desai, Doralisa Morrone, Mandeep S. Sidhu, William E. Boden · 2017 · Reviews in Cardiovascular Medicine
7. Is the Search for Enough Moderate-Severe Ischemia Nearly Over?
   Raymond J. Gibbons · 2019 · JAMA Cardiology
8. Revascularization Strategies for Non-ST-Elevation Myocardial Infarction
   Bennet George, Naoki Misumida, Khaled M. Ziada · 2019 · Current Cardiology Reports
9. Improving outcomes of percutaneous coronary interventions in patients with stable ischemic heart disease
   Dhavalkumar B. Patel, Rachit M. Shah, Ion S. Jovin · 2020 · Journal of Thoracic Disease
10. Impact of Diabetes Mellitus on Mortality and Hospitalization in Patients With Mild-to-Moderate Cardiomyopathy
    Ankit N. Medhekar, Suresh R Mulukutla, Floyd W. Thoma, Norman C. Wang, Adithya Bhonsale, Krishna Kancharla, N.A. Mark Estes, Sandeep K Jain, Samir Saba · 2020 · JACC. Clinical electrophysiology
11. Effect of Yugengtongyu Granules in Patients with Stable Coronary Artery Disease on Reducing Adverse Cardiovascular Events: A Double-Blind Controlled Trial
    Dayang Wang, Chunyan Li, Xiaoqing Xu, Hui Xu, Congcong Guo, Jinping Wang, Jingyin Guo, Li Huang · 2020 · The Journal of Alternative and Complementary Medicine
12. The effects of insulin therapy on mortality in diabetic patients undergoing percutaneous coronary intervention
    Shaopeng Xu, Bei Wang, Wennan Liu, Chengcheng Wu, Jinyong Huang · 2021 · Annals of Translational Medicine
13. Renal outcomes associated with glucose-lowering agents: Systematic review and meta-analysis of randomized outcome trials
    Konstantina Chalmoukou, Dimitris Polyzos, Eleni Manta, Fotis Tatakis, D. Konstantinidis, Costas Thomopoulos, Tsioufis Costas · 2021 · European Journal of Internal Medicine
14. Prognostic Value of Serial Coronary CT Angiography in Atherosclerotic Plaque Modification: What Have We Learnt?
    Venkat Sanjay Manubolu, Sion K. Roy, Matthew Jay Budoff · 2022 · Current Cardiovascular Imaging Reports
15. Outcomes of Myocardial Revascularization in Diabetic Patients With Left Main Coronary Artery Disease: A Multicenter Observational Study From Three Gulf Countries
    Amin Daoulah, Amr Elfarnawany, Turki Al Garni, Ahmad Salah Hersi, Mohammed Alshehri, Wael A. Almahmeed, Nooraldaem Yousif, Reda Abuelatta, Abdulaziz Saud Alasmari, Nezar Essam Elsheikh-Mohamed et al. · 2022 · Cardiovascular revascularization medicine
16. Identifying and Treating Vulnerable Atherosclerotic Plaques
    John A. Ambrose, Avinash V. Sharma · 2023 · The American Journal of Cardiology
17. Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?
    Stefano Benenati, Giovanni Luigi De Maria, Rafail Angelos Kotronias, Italo Porto, ADRIAN P BANNING · 2023 · Open Heart
18. Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease
    Sandra A. Weiss, William S. Weintraub · 2015 · Progress in Cardiovascular Diseases
19. Diabetes und Herzinsuffizienz
    Christian Alfons Schneider, Roman Pfister, Erland Erdmann · 2010 · Herz
20. Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements
    Fred Yang, David L. DeMets, Murray W Stewart, June Ye · 2015 · Diabetes Metabolic Syndrome and Obesity
21. Wytyczne ESC dotyczące cukrzycy, stanu przedcukrzycowego i chorób układu sercowo- -naczyniowego opracowane we współpracy z EASD
    ESC EASD · 2013 · Kardiologia Polska
22. Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced?
    Ralf E. Harskamp, Duk‐Woo Park · 2013 · Expert Review of Cardiovascular Therapy
23. Interactions Between Cardiovascular and Cerebrovascular Disease
    Giuseppe Di Pasquale, Stefano Urbinati, Enrica Perugini, Simona Gambetti · 2012 · Current Treatment Options in Neurology
24. Cardiovascular Importance of Hyperglycemia and Hypoglycemia
    Ivan Tkáč · 2013 · Diabetes Care
25. Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology
    Robert A. Henderson, Adam Timmis · 2011 · Heart
26. Chronic Coronary Artery Disease
    Rodrigo M. Lago, Thomas A. LaMattina · 2013 · Springer eBooks
27. Impact of myocardial ischemia on myocardial revascularization in stable ischemic heart disease
    Mikhail T. Torosoff, Mandeep S. Sidhu, William E. Boden · 2013 · Herz
28. Coronary Stents in Diabetic Patients: State of the Knowledge
    Pablo Codner, Hitinder Singh Gurm, Apurva A. Motivala · 2017 · Current Cardiology Reports
29. State of the art: optimal medical therapy – competing with or complementary to revascularisation in patients with coronary artery disease?
    Javaid Iqbal, Robert Jay Widmer, Bernard John Gersh · 2017 · EuroIntervention
30. On-Pump Coronary Artery Bypass Graft: The State of the Art.
    G. Cuminetti, I. Bonadei, E. Vizzardi, E. Sciatti, R. Lorusso · 2019 · Reviews on recent clinical trials
31. Weighing Coronary Revascularization Options in Patients With Type 2 Diabetes Mellitus
    Lucas C. Godoy, Caio A.M. Tavares, Michael E. Farkouh · 2019 · Canadian Journal of Diabetes
32. The Management of Coronary Artery Disease in Ethiopia: Emphasis on Revascularization
    Bekele Alemayehu Shashu · 2021 · Ethiopian Journal of Health Sciences
33. Guidelines for the Clinical Application of Bypass Grafts and the Surgical Techniques (JCS 2011) Published in 2012
    JCS Joint Working Group · 2013 · Circulation Journal
34. Coronary Artery Bypass Grafting
    Talal Al‐Atassi, Hadi Daood Toeg, Vincent Chan, Marc Ruel · 2016 · Elsevier eBooks
35. Historical Milestones in the Management of Stable Coronary Artery Disease over the Last Half Century
    William S. Weintraub, David Paul Taggart, G.B. John Mancini, David Brown, William E. Boden · 2018 · The American Journal of Medicine
36. NHLBI Integrated Pediatric Guidelines: Battle for a Future Free of Cardiovascular Disease
    Justin P.V. Zachariah, Sarah D. de Ferranti · 2012 · Future Cardiology
37. Insulin glargine and cancer: cause and effect unproven
    Daniel R Owens, Julio Rosenstock, Geremia B. Bolli · 2009 · Practical Diabetes
38. Diabetes and Screening for Coronary Heart Disease: Where Should We Focus our Efforts?
    Jesús M. de la Hera, José Manuel García‐Ruiz, Elías Delgado · 2015 · Revista Española de Cardiología (English Edition)
39. Optimal Medical Therapy vs CT Angiography Screening for Patients With Diabetes
    Raymond J. Gibbons · 2014 · JAMA
40. Is it Form or Function?
    Spencer B. King · 2014 · JACC: Cardiovascular Interventions
41. Why coronary artery bypass grafting remains the standard of care for patients with complex, multivessel coronary artery disease
    Joseph F. Sabik · 2016 · Journal of Thoracic and Cardiovascular Surgery
42. Impact of Total Risk Management on Coronary Plaque Regression in Diabetic Patients with Acute Coronary Syndrome
    Ryo Naito, Katsumi Miyauchi, Hiroyuki Daida, Takeshi Morimoto, Takafumi Hiro, Takeshi Kimura, Yoshihisa Nakagawa, Masakazu Yamagishi, Yukio Ozaki, Masunori Matsuzaki et al. · 2016 · Journal of Atherosclerosis and Thrombosis
43. A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes
    Michael E. Nassif, Mikhail Kosiborod · 2019 · The American Journal of Medicine
44. Completeness of revascularization and its impact on the outcomes of a staged approach of percutaneous coronary intervention followed by minimally invasive valve surgery for patients with concomitant coronary artery and valvular heart disease
    Andrés M. Pineda, Ramesh Chandra, Saqib Ali Gowani, Orlando Santana, Christos G. Mihos, Ajay Jayant Kirtane, Gregg W. Stone, Paul A. Kurlansky, Craig R. Smith, Nirat Beohar · 2015 · Catheterization and Cardiovascular Interventions
45. Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice
    Ruben L.J. Osnabrugge, Stuart J. Head, Ad J.J.C. Bogers, A. Pieter Kappetein · 2013 · Expert Review of Cardiovascular Therapy
46. Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial
    Edward Y. Sako, Maria M. Brooks, Regina M. Hardison, Hartzell Vernon Schaff, Robert L. Frye · 2014 · Journal of Thoracic and Cardiovascular Surgery
47. General Cardiology Perspective: Decision Making Regarding Revascularization of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
    Valentı́n Fuster, Michael E. Farkouh · 2010 · Circulation
48. CABG Versus PCI in the Treatment of Diabetic Patients Affected by Coronary Artery Disease
    Francesco Nicolini, Andrea Agostinelli, Antonella Vezzani, Filippo Benassi, Tiziano Gherli · 2014 · International Heart Journal
49. Overdiagnosis of Coronary Artery Disease Detected by Coronary Computed Tomography Angiography
    Torrey Richard Schmidt, Ronald Maag, Andrew Foy · 2016 · JAMA Internal Medicine
50. Impact of intensively lowered low‐density lipoprotein cholesterol on deferred lesion prognosis
    Shun Nakamura, Takanobu Yamamoto, Yun Teng, Sawa Matsumoto, Kensuke Kasano, Hirotaka Yoshiwara, Eijiro Hattori, Takeshi Tokunaga, Taishi Yonetsu, Kenzo Hirao · 2019 · Catheterization and Cardiovascular Interventions
51. Late clinical outcomes of unselected patients with diabetic mellitus and multi-vessel coronary artery disease
    Mohamed Eftal Bin Mohamed Ebrahim, Rebecca J. Dignan, Giuseppe Femia, Samuel Kim, Gabriel A Gregory, Sonya N. Burgess, Leia Hee, C. Mussap, Waleed Aty, Sidney T. Lo et al. · 2019 · International Journal of Cardiology
52. Detecting unstable plaques in humans using cardiac CT: Can it guide treatments?
    Marwa Daghem, David Ernest Newby · 2019 · British Journal of Pharmacology
53. Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease
    Nevio Taglieri, Antonio Giulio Bruno, Maria Letizia Bacchi Reggiani, Emanuela Concetta D’Angelo, Gabriele Ghetti, Matteo Bruno, Tullio Palmerini, Claudio Rapezzi, Nazzareno Galiè, Francesco Saia · 2020 · International Journal of Cardiology
54. COURAGE, ORBITA, and ISCHEMIA
    Zhi Hao Teoh, Rasha Kadem Al-Lamee · 2020 · Interventional Cardiology Clinics
55. Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort study
    Alexander Zabala, Anders Gottsäter, Marcus Lind, Ann‐Marie Svensson, Björn Eliasson, Rebecka Bertilsson, Jan Ekelund, Thomas Nyström, Magnus Jonsson · 2021 · Cardiovascular Diabetology
56. The advantage of surgical revascularization in diabetic patients with multivessel disease: More arterial conduits, more benefit.
    R. Akhrass, F. Bakaeen · 2021 · Journal of Thoracic and Cardiovascular Surgery
57. The New Role of Cardiac Imaging Following the ISCHEMIA Trial
    Christopher A. Hanson, Toral R. Patel, Todd C. Villines · 2021 · Current Treatment Options in Cardiovascular Medicine
58. ISCHEMIA Trial: Key Questions and Answers
    Jose Luis Lopez-Sendon, Raúl Moreno, Juan Luis Tamargo · 2021 · European Cardiology Review
59. Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function
    Sripal Bangalore, Judith S. Hochman, Susanna R. Stevens, Philip G. Jones, John A. Spertus, Sean M. O’Brien, Harmony R. Reynolds, William E. Boden, Jerome L. Fleg, David O. Williams et al. · 2022 · JAMA Cardiology
60. Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease
    William E. Boden, Peter Howard Stone · 2022 · Annual Review of Medicine
61. Cardiovascular Outcomes of Redo-coronary Artery Bypass Graft Versus Percutaneous Coronary Intervention of Index Bypass Grafts Among Acute Coronary Syndrome: Regression Matched National Cohort Study
    Mohammed Faisaluddin, Yasar Sattar, Nouraldeen Manasrah, Neel Patel, Amro Taha, Andrew Takla, Asmaa Ahmed, Mohammed Osama, Anoop Titus, Mohammad Hamza et al. · 2023 · Current Problems in Cardiology
62. Effects of Elective Coronary Revascularization vs Medical Therapy Alone on Noncardiac Mortality
    Eliano Pio Navarese, Alexandra J. Lansky, Michael E. Farkouh, Klaudyna Grzelakowska, Marc P. Bonaca, Diana Adrienne Gorog, Paolo Raggi, Malte Kelm, Brandon Yeo, Julia Maria Umińska et al. · 2023 · JACC: Cardiovascular Interventions
63. Diagnostik und Therapie der chronisch stabilen koronaren Herzkrankheit
    Anastasios Athanasiadis, Udo P Sechtem · 2014 · Herz
64. Screening asymptomatic patients with type 2 diabetes is recommended—Con
    Raymond J. Gibbons · 2015 · Journal of Nuclear Cardiology
65. Timely publication and sharing of trial data: opportunities and challenges for comparative effectiveness research in cardiovascular disease
    Huseyin Naci, Jacob Cooper, Elias A. Mossialos · 2015 · European Heart Journal - Quality of Care and Clinical Outcomes
66. Appropriate Revascularization in Stable Angina: Lessons From the BARI 2D Trial
    Ronald J. Krone, Andrew D. Althouse, Jacqueline E. Tamis‐Holland, Lakshmi Venkitachalam, Arturo Campos, Alan D. Forker, Alice K. Jacobs, Salvador Ocampo, George A. Steiner, Francisco Fuentes et al. · 2014 · Canadian Journal of Cardiology
67. Conservative strategy for treatment of stable coronary artery disease
    Paulo Cury Rezende · 2015 · World Journal of Clinical Cases
68. Similar Outcome in Insulin-Dependent and Noninsulin-Dependent Diabetic Patients After Off-Pump Coronary Artery Bypass Grafting With Multiple Skeletonized Arterial Conduits
    Tomoaki Suzuki, Tohru Asai, Hiromitsu Nota, Takeshi Kinoshita, Susumu Fujino, Noriyuki Takashima · 2015 · The Annals of Thoracic Surgery
69. Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen
    Juan José Chillarón · 2014 · World Journal of Clinical Cases
70. Treatment strategies for chronic stable angina
    Juan Carlos Kaski, Antonio Luis Arrebola-Moreno, Jason N. Dungu · 2011 · Expert Opinion on Pharmacotherapy
71. Chronic stable angina: percutaneous coronary intervention or medication?
    Dimitrios Maragiannis, George A. Lazaros, Manolis Vavuranakis, Christina A. Chrysohoou, Stavroula Athanassopoulou, Athanassios Patialiakas, Christodoulos Stefanadis · 2011 · PubMed
72. New methods in diagnostic and therapy Invasive and non-invasive fractional flow reserve index in validation of hemodynamic severity of intracoronary lesions
    Jarosław P. Wasilewski, Kryspin Mirota, Michał Hawranek, Lech Poloński · 2013 · Advances in Interventional Cardiology
73. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
    Martin Clodi, Heidemarie Abrahamian, Heinz Drexel, Peter Fasching, Bernhard Föger, Claudia Maria Francesconi, Friedrich Hoppichler, Susanne Kaser, Alexandra Kautzky‐Willer, Monika Lechleitner et al. · 2016 · Wiener klinische Wochenschrift
74. Transcatheter versus surgical intervention: lessons from trials of coronary revascularisation
    Julian P. Gunn, David Paul Taggart · 2019 · Heart
75. Development of a risk score to identify patients with type 2 diabetes mellitus and multivessel coronary artery disease who can defer bypass surgery
    Andrew Perry, Matthew J. Chung, Eric L. Novak, Ronald J. Krone, David Brown · 2019 · Diagnostic and Prognostic Research
76. Effects of glucose-lowering on outcome incidence in diabetes mellitus and the modulating role of blood pressure and other clinical variables
    Costas Thomopoulos, George Bazoukis, Ιoannis Ilias, Costas P. Tsioufis, Thomas Makris · 2019 · Journal of Hypertension
77. Noninvasive assessment of coronary atherosclerosis by cardiac computed tomography for risk stratifying patients with suspected coronary heart disease
    Alexander R. van Rosendael, Jeroen Joost Bax, Armin Arbab‐Zadeh · 2019 · Journal of cardiovascular computed tomography
78. Meta-Analysis of the Effect of Percutaneous Coronary Intervention on Death and Myocardial Infarction in Patients With Stable Coronary Artery Disease and Inducible Myocardial Ischemia
    Qais Radaideh, Mohammed Osman, Babikir Kheiri, Ahmad Al‐Abdouh, Mahmoud Barbarawi, Ghassan I. Bachuwa, Jacqueline E. Tamis‐Holland, Nicolas W. Shammas, William E. Boden · 2020 · The American Journal of Cardiology
79. ISCHEMIA Trial
    Rory Hachamovitch, Prem Soman · 2021 · Circulation Cardiovascular Imaging
80. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program
    Todd J. Brophy, Theodore J. Warsavage, Annika L. Hebbe, Mary E. Plomondon, Stephen W. Waldo, Sunil V. Rao, Adam D. DeVore, Jorge Antonio Gutierrez, Rajesh V. Swaminathan · 2021 · American Heart Journal
81. Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry
    M. Bilal Iqbal, Peter T. Moore, Imad J. Nadra, Simon D. Robinson, Eric Fretz, Lillian Ding, Anthony Fung, Eve D. Aymong, Albert W. Chan, Steven Hodge et al. · 2021 · Catheterization and Cardiovascular Interventions
82. Extra-Glycemic Effects of Anti-Diabetic Medications: Two Birds with One Stone?
    Eun‐Jung Rhee · 2022 · Endocrinology and Metabolism
83. Role of Fractional-Flow Reserve in Guiding Percutaneous Revascularization in Stable Coronary Artery Disease
    Nikolaos Kakouros, Jeffrey J. Rade · 2015 · Current Atherosclerosis Reports
84. Management of Patients With Stable Angina and Type 2 Diabetes
    PRAKASH C. DEEDWANIA · 2015 · Reviews in Cardiovascular Medicine
85. Glycemia and cardiovascular risk: challenging evidence based medicine.
    Konstantinos Kitsios, Απόστολος Τσάπας, P Karagianni · 2011 · PubMed Central
86. Management of Type 2 Diabetes Mellitus
    Kathleen Marie Dungan · 2015 · Elsevier eBooks
87. Myocardial revascularization in patients with type 2 diabetes mellitus: An overview of modern techniques
    Elena Zelikovna Golukhova, Elena Vladislavovna Kuznetsova · 2016 · Diabetes Mellitus
88. Challenges with Evidence-Based Management of Stable Ischemic Heart Disease
    Amit Patel, Sripal Bangalore · 2017 · Current Cardiology Reports
89. Effect of Percutaneous Coronary Intervention on Survival in Patients with Stable Ischemic Heart Disease
    Francisco Ujueta, Ephraim N. Weiss, Binita Shah, Steven P. Sedlis · 2017 · Current Cardiology Reports
90. Oral diabetes medication monotherapy and short-term mortality in individuals with type 2 diabetes and coronary artery disease
    Sridharan Raghavan, Wenhui G. Liu, David R. Saxon, Gary K. Grunwald, Thomas M. Maddox, Jane E.B. Reusch, Seth A. Berkowitz, Liron Caplan · 2018 · BMJ Open Diabetes Research & Care
91. Quality of health economic evaluations for the ACC/AHA stable ischemic heart disease practice guideline: A systematic review
    Elizabeth R. Stevens, Daniel Farrell, Saahil A. Jumkhawala, Joseph A. Ladapo · 2018 · American Heart Journal
92. Does CHA2DS2-VASc Score Predict MACE in Patients Undergoing Isolated Coronary Artery Bypass Grafting Surgery?
    Muhsin Kalyoncuoğlu, Semi Öztürk, Mazlum Şahın · 2019 · Brazilian Journal of Cardiovascular Surgery
93. Clinical evidence versus patients’ perception of coronary revascularization
    Michio Kawasuji · 2013 · Surgery Today
94. The Genetic and Metabolic Determinants of Cardiovascular Complications in Type 2 Diabetes: Recent Insights from Animal Models and Clinical Investigations
    Rita Kohen Avramoglu, Marc‐André Laplante, Khaï Le Quang, Yves Deshaies, Jean‐Pierre Després, Éric Larose, Patrick Mathieu, Paul Poirier, Louis Përusse, Marie‐Claude Vohl et al. · 2013 · Canadian Journal of Diabetes
95. Editorials Editorial on management of diabetes mellitus with coronary artery disease
    Wilbert S. Aronow · 2011 · Archives of Medical Science
96. Therapies for Type 2 Diabetes and Coronary Artery Disease
    Matthias E Pfisterer, Michael J Zellweger · 2009 · New England Journal of Medicine
97. PCI and CABG for Treating Stable Coronary Artery Disease
    Doenst, Torsten, Haverich, Axel, Serruys, Patrick, Bonow, Robert O., Kappetein, Pieter, Falk, Volkmar, Velazquez, Eric, Diegeler, Anno, Sigusch, Holger · 2019 · Journal of the American College of Cardiology
98. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes
    Farkouh, Michael E., Domanski, Michael, Dangas, George D., Godoy, Lucas C., Mack, Michael J., Siami, Flora S., Hamza, Taye H., Shah, Binita, Stefanini, Giulio G., Sidhu, Mandeep S. et al. · 2019 · Journal of the American College of Cardiology
99. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes
    Farkouh, Michael E., Sidhu, Mandeep S., Brooks, Maria M., Vlachos, Helen, Boden, William E., Frye, Robert L., Hartigan, Pamela, Siami, F.S., Bittner, Vera A., Chaitman, Bernard R. et al. · 2019 · Journal of the American College of Cardiology